Biosplice Therapeutics vs Surrozen
Biosplice Therapeutics
Restore health by delivering first-in-class therapies that harness alternative splicing
37 employees · est. 2008 · San Diego, United States
Surrozen
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway
67 employees · est. 2016 · South San Francisco, United...
Biosplice Therapeutics is the older company (2008 vs 2016); Surrozen is the larger of the two.
Side-by-Side Comparison
| Metric | Biosplice Therapeutics | Surrozen |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2016 |
| Headquarters | ||
| Headquarters | San Diego, United States | South San Francisco, United States |
| Employees | ||
| Employees | 37 | 67 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Grant | Not tracked yet |
| Total Funding | ||
| Total Funding | $778.00M | $445.50M |
| Funding Rounds | ||
| Funding Rounds | 6 | 7 |
| Services | ||
| Services | Therapeutic Modulation of Alternative Splicing | Development of Multi-target Antibody Therapeutics, Modulation of Wnt Signaling Pathway |
| Target Customers | ||
| Target Customers | Patients with Osteoarthritis, Cancer, Neurological Disorders, and Diabetes | Patients with Ophthalmic Diseases, Healthcare Providers, Biotechnology and Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Medical ResearchTherapeutics DevelopmentRegenerative MedicineOncologyDegenerative DiseasesAlternative Splicing +8 | Regenerative MedicineWnt Signaling PathwayTissue-Specific AntibodiesDrug DiscoveryTherapeutic DevelopmentSelf-Renewal Properties +8 |
| Website | ||
| Website | biosplice.com | surrozen.com |
About Biosplice Therapeutics
Biosplice Therapeutics, founded in 2008 and headquartered in the United States, is dedicated to restoring health by delivering pioneering therapies that leverage alternative splicing. The company's focus on small-molecule therapeutics, rooted in the groundbreaking science of alternative pre-mRNA spl...
About Surrozen
Surrozen is a biotechnology company specializing in the discovery and development of innovative regenerative medicines. The company aims to harness the self-renewal properties of the body by precisely controlling the Wnt signaling pathway. Founded in 2016 by a team of five trailblazing scientists,...
Also comparing in this category
Comparing more than these two?
Get Biosplice Therapeutics, Surrozen and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Biosplice Therapeutics compare?
A PDF of Biosplice Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Biosplice Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Biosplice Therapeutics on 24 Mar 2025, and Surrozen on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.